RT期刊文章SR电子T1对Covid-19患者风险分层和治疗的护理点肺超声评估。一项潜在的非介入研究JF欧洲呼吸杂志Jo EUR RESPIR J FD欧洲呼吸学会SP 2004283 DO 10.1183 / 13993003.04283-2020 A1 R188bet官网地址ubio-Gracia，豪尔赫A1Giménez-López，Ignacio A1Garcés-Horna，Vanesa A1López-德尔戈多，丹尼尔A1 Sierra-Monzón，Jose Luis A1Martínez-Lostao，Luis A1 josa-laorden，Claudia A1 Ruiz-Laiglesia，Fernando A1Pérez-Calvo，Juanando Ignacio A1 Crespo-Aznarez，Silvia A1García-Lafuente，Javier A1PeñaFresneda，Natasha A1Amores Arriaga，Betriz A1 Gracia-Tello，Borja A1Sánchez-Marteles，Marta Yr 2021 UL //www.qdcxjkg.com/content/early/2021/02/04/13993003.04/13993003.04/13993003.04/13993003.04/13993003.04/13993003.04/13993003.04/13993003.04283-2020.abstract ab背景肺超声（lus）可行用于评估Covid-19引起的肺损伤。然而，在Covid-19住院患者中，LUS评估的肺损伤的预后意义和时间线变化是未知的。旨在通过使用定量规模来分析Covid-19患者中LU的预后价值（LUZ-得分）在入场后的前72小时内。主要终点是医院死亡和/或入院的重症监护单位。在前72小时期间住院住院总长度，氧气流量增加或升级的医疗，是次要终点。结果130名患者终止于终点;平均年龄为56.7±13.5岁。自症状开始以来的时间为入院6天（4-9）。通过Luz分数评估的肺损伤在前72小时内没有不同（在入场时21分[16-26]，72小时的20分[16-27]; p = 0.183）。 In univariable logistic regression analysis estimated PaO2/FiO2 (HR 0.99 [0.98–0.99]; p=0.027) and LUZ-score>22 points (5.45 (1.42–20.90); p=0.013) were predictors for the primary endpoint.Conclusions LUZ-score is an easy, simple and fast point of care ultrasound tool to identify patients with severe lung injury due to COVID-19, upon admission. Baseline score is predictive of severity along the whole period of hospitalisation. The score facilitates early implementation or intensification of treatment for COVID-19 infection. LUZ-score may be combined with clinical variables (as estimated PAFI) to further refine risk stratification.Lung injury caused by COVID-19 can be measured through lung ultrasound (LUS). LUS identify COVID-19 patients at a higher risk of complications. LUS could support clinical-decision making in COVID-19 patients.